Lepu Biopharma Co., Ltd. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of drugs for cancer targeted therapy and oncology immunotherapy. The company was founded by Zhong Jie Pu on January 19, 2018 and is headquartered in Shanghai, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company